Bellicum Pharmaceuticals Growth, Revenue, Number of Employees and Funding

Overview

Location:
Houston, TX USA
Total Funding:$301.8M
Industry:Biotech
Founded:2003
Lead Investor(s):Citigroup, Jefferies LLC
Press

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Bellicum Pharmaceuticals's estimated revenue is currently $1.1M per year.
  • Bellicum Pharmaceuticals received $Undisclosed in venture funding in April 2018.
  • Bellicum Pharmaceuticals's estimated revenue per employee is $7568
  • Bellicum Pharmaceuticals's total funding is $301.8M.

Employee Data

  • Bellicum Pharmaceuticals has 148 Employees.
  • Bellicum Pharmaceuticals grew their employee count by -11% last year.
  • Bellicum Pharmaceuticals currently has 1 job openings.

Executive Contacts

NameTitle
David SpencerChief Scientific Officer
Joseph SenesacVP Manufacturing/Viral Vector Development
Rick FairPresident & CEO
Scott CullisonVice President, Commercial Planning and Program Management
Kim LuuDirector Analytical
Eric BourhisDirector, Business Development & Strategy
Steve TolerVice President, Pharmaceutical Development
Kurt MickelsonDirector - Clinical Supply Chain
Joanna StansonDirector, Contract Manufacturing Relations
Aaron FosterVice President of Product Discovery

What Is Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals, located near the Houston Medical Center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. We are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT) and CAR T cell therapy. We are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives.

keywords:Biotechnology,Healthcare,Pharmaceuticals

148

Number of Employees

$1.1M

Revenue (est)

1

Current Jobs

-11%

Employee Growth %

$301.8M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Bellicum Pharma...
$1.1M148-11%$301.8M
G-CON Manufactu...
$8.8M6133%
BioNews Service...
$8.7M6011%
Luminex Corpora...
$158.4M109410%
Family Tree DNA
$5.7M4018%
XBiotech USA
$10.9M7512%
Celling Bioscie...
$9M62-2%
Gradalis
$6.2M4343%$40M
Myriad RBM
$16.7M1167%
Selleck Chemica...
$22M1528%

Bellicum Pharmaceuticals News

09/03/2019 - CORRECTING and REPLACING -Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals Announces Pricing of $139.6 Million Public Offering and Private Placement. Pricing of $57.5 Million Public Offering of ...

09/08/2019 - Bellicum Pharma launches $53M equity offering

Bellicum Pharmaceuticals (NASDAQ:BLCM) is offering to sell shares of its Series 1 preferred stock and warrants to purchase common shares in ...

09/03/2019 - Bellicum Pharma (BLCM) Prices $139.6 Million Public Offering ...

Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan ...

Bellicum Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2009-10-28$4.5MAArticle
2010-12-22$3.0MUndisclosedArticle
2012-03-09$20.0MBAVG Ventures LP, Remeditex VenturesArticle
2014-01-08$34.4MBAVG VenturesArticle
2014-08-28$55.0MCMultipleArticle
2017-03-31$69.0MUndisclosedCitigroupArticle
2018-04-18$UndisclosedUndisclosedCitigroupArticle

Bellicum Pharmaceuticals Executive Hires

DateNameTitleReference
2007-10-11Amount: 3.75Round: UndisclosedArticle
2012-04-13David M. SpencerChief Scientific OfficerArticle
2014-12-08Alan MussoCFO/TreasurerArticle
2015-10-30Alan K SmithSVP ManufacturingArticle
2017-08-04Gregory NaeveChief Business OfficerArticle
2018-02-06William GrossmanChief Medical OfficerArticle
2018-05-30Shane WardGeneral Counsel and Corporate SecretaryArticle
2018-12-14Atabak MokariCFOArticle